U.S. FDA

FDA Approves First Factor Xla Inhibitor to Help Prevent Stroke in Certain Adults at High Risk

FDA today approved Sunharbo (asundexian) 50 mg tablets, the first factor XIa (FXIa) inhibitor for use in combination with antiplatelet therapy to…